Literature DB >> 12402334

Different molecular mechanisms underlie genomic deletions in the MLH1 Gene.

Alessandra Viel1, Fiorella Petronzelli, Lara Della Puppa, Emanuela Lucci-Cordisco, Mara Fornasarig, Salvatore Pucciarelli, Valentina Rovella, Michele Quaia, Maurizio Ponz de Leon, Mauro Boiocchi, Maurizio Genuardi.   

Abstract

In this study we examined a series of 52 patients belonging to hereditary nonpolyposis colorectal cancer (HNPCC) or HNPCC-related families, all who had previously tested negative for mismatch repair (MMR) gene point mutations. Southern blot mutational screening of MLH1 and MSH2 genes was carried out with the aim of detecting large genomic rearrangements and of identifying the molecular mechanisms underlying the inactivation of the MMR genes. Three patients had abnormal restriction patterns and were found to carry distinct MLH1 internal deletions. Long-range PCRs identified the loss of DNA tracts spanning exon 6 (about 2.4 kb in proband A-AV20 and 0.8 kb in proband A-PD5) and exon 3 (about 2.5 kb in proband R-RM2). In A-AV20 the breakpoints occurred into identical 33-bp regions in introns 5 and 6 and a mechanism of classical Alu-mediated homologous recombination was evident. Also, in patient A-PD5 the breakpoints were located in these introns, but without direct involvement of repetitive sequences. In patient R-RM2 the breakpoints were located within repetitive L1 elements with poor homology in intron 2 and 3 and the rearranged allele was characterized by a complex insertion deletion (delCCinsACATAGTA), giving rise to a palindromic CTTAACATAGTATGTTAAG sequence in proximity of the fusion site. This study confirms that genomic rearrangements are an important component of the spectrum of MMR mutations. Although Alu repeats are likely to be implicated in the majority of cases, different molecular mechanisms may also be responsible for the observed MLH1 intragenic deletions. In particular, HNPCC resulting from L1-mediated recombination has been identified as a novel mechanism for MMR inactivating mutation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402334     DOI: 10.1002/humu.10138

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

Review 1.  All y'all need to know 'bout retroelements in cancer.

Authors:  Victoria P Belancio; Astrid M Roy-Engel; Prescott L Deininger
Journal:  Semin Cancer Biol       Date:  2010-06-25       Impact factor: 15.707

2.  Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.

Authors:  James Mueller; Isabella Gazzoli; Prathap Bandipalliam; Judy E Garber; Sapna Syngal; Richard D Kolodner
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

3.  Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.

Authors:  Sana Aissi-Ben Moussa; Amel Moussa; Tonio Lovecchio; Nadia Kourda; Taoufik Najjar; Sarra Ben Jilani; Amel El Gaaied; Nicole Porchet; Mohamed Manai; Marie-Pierre Buisine
Journal:  Fam Cancer       Date:  2008-09-16       Impact factor: 2.375

4.  The value of multi-modal gene screening in HNPCC in Quebec: three mutations in mismatch repair genes that would have not been correctly identified by genomic DNA sequencing alone.

Authors:  Susan McVety; Lili Li; Isabelle Thiffault; Philip H Gordon; Elizabeth Macnamara; Nora Wong; Karlene Australie; Lidia Kasprzak; George Chong; William D Foulkes
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

5.  Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

Authors:  Georgia Thodi; Florentia Fostira; Raphael Sandaltzopoulos; George Nasioulas; Anastasios Grivas; Ioannis Boukovinas; Maria Mylonaki; Christos Panopoulos; Mirjana Brankovic Magic; George Fountzilas; Drakoulis Yannoukakos
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

6.  Alu distribution and mutation types of cancer genes.

Authors:  Wensheng Zhang; Andrea Edwards; Wei Fan; Prescott Deininger; Kun Zhang
Journal:  BMC Genomics       Date:  2011-03-23       Impact factor: 3.969

7.  L1 retrotransposons in human cancers.

Authors:  Wolfgang A Schulz
Journal:  J Biomed Biotechnol       Date:  2006

8.  Germline truncating mutations in both MSH2 and BRCA2 in a single kindred.

Authors:  I Thiffault; N Hamel; T Pal; S McVety; V A Marcus; D Farber; S Cowie; J Deschênes; W Meschino; F Odefrey; D Goldgar; T Graham; S Narod; A K Watters; E MacNamara; D Du Sart; G Chong; W D Foulkes
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

9.  The contribution of alu elements to mutagenic DNA double-strand break repair.

Authors:  Maria E Morales; Travis B White; Vincent A Streva; Cecily B DeFreece; Dale J Hedges; Prescott L Deininger
Journal:  PLoS Genet       Date:  2015-03-11       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.